NeuroPace, Inc.
(NASDAQ : NPCE)

( )
NPCE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.03%535.631.0%$648.52m
DHRDanaher Corp. 0.36%252.780.7%$635.19m
MDTMedtronic Plc 1.28%90.340.6%$612.83m
ABTAbbott Laboratories 1.91%109.010.8%$601.34m
ISRGIntuitive Surgical, Inc. 0.30%202.590.8%$423.22m
BSXBoston Scientific Corp. 0.77%37.791.0%$333.72m
ALGNAlign Technology, Inc. 0.10%242.156.4%$293.90m
BDXBecton, Dickinson & Co. 1.93%249.251.0%$275.67m
EWEdwards Lifesciences Corp. 1.33%95.990.4%$271.04m
SYKStryker Corp. 0.89%198.861.3%$258.39m
IDXXIDEXX Laboratories, Inc. 2.58%358.223.8%$231.23m
AAgilent Technologies, Inc. 0.63%117.801.7%$206.87m
BAXBaxter International, Inc. 0.82%65.791.8%$203.09m
DXCMDexCom, Inc. 1.00%75.451.9%$174.20m
SWAVShockwave Medical, Inc. -0.60%194.370.0%$168.16m

Company Profile

NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's product RNS system is designed for the treatment of medically refractory partial epilepsy includes implantable and external products. The company was founded by Robert Fischell, David Fischell, Tim Fischell, Scott Fischell, Rebecca L. Kuhn, Frank M. Fischer and Martha Morrell on November 19, 1997 and is headquartered in Mountain View, CA.